Wall Street analyst estimates for Church & Dwight Co., Inc. (CHD): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Church & Dwight Co., Inc. is a company dedicated to the creation, production, and marketing of a diverse portfolio encompassing household, personal care, and specialized industrial goods. Its operations are structured into three principal divisions: Consumer Domestic, Consumer International, and the Specialty Products Division. The company offers a broad array of well-known consumer brands.
Consensus price target
$105.89 (-4 % vs price $110.45)
between $83.00 and $115.00 · 7 targets published in the last quarter
Closing price, Nov 2
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $6.2B | $6.2B – $6.3B | $3.78 | 9 |
| 2027E | $6.5B | $6.4B – $6.6B | $4.04 | 11 |
Figures in USD · consensus as of November 2, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 18 |
| Hold | 15 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 34 |
| Avg rating (−2 sell to +2 buy) | 0.50 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2027-01-29 | $1.02 | ||
| 2026-10-30 | $0.92 | $0.90 | +2.2% |
| 2026-07-31 | $0.89 | $0.90 | -0.7% |
| 2026-05-01 | $0.95 | $0.93 | +2.0% |
| 2026-01-30 | $0.86 | $0.84 | +2.9% |
| 2025-10-31 | $0.81 | $0.74 | +10.1% |
| 2025-08-01 | $0.94 | $0.86 | +9.7% |
| 2025-05-01 | $0.91 | $0.90 | +1.6% |
Valuation Ratios
| P/E Ratio | 33.98 |
| Price / Book | 5.84 |
| Dividend Yield | 1.10% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.49B | $3.78B | $4.15B | $4.36B | $4.90B | $5.19B | $5.38B | $5.87B | $6.11B | $6.20B |
| Cost of Revenue | $1.90B | $2.05B | $2.31B | $2.37B | $2.68B | $2.93B | $3.13B | $3.28B | $3.32B | $3.43B |
| Gross Profit | $1.59B | $1.73B | $1.84B | $1.98B | $2.21B | $2.26B | $2.25B | $2.59B | $2.79B | $2.77B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $866.4M | $996.9M | $1.05B | $1.14B | $1.18B | $1.18B | $1.24B | $1.53B | $1.63B | $1.70B |
| Operating Expenses | $866.4M | $996.9M | $1.05B | $1.14B | $1.18B | $1.18B | $1.65B | $1.53B | $1.98B | $1.70B |
| Operating Income | $724.2M | $732.7M | $791.7M | $840.2M | $1.03B | $1.08B | $597.8M | $1.06B | $807.1M | $1.08B |
| EBITDA | $841.2M | $870.7M | $940.0M | $1.02B | $1.22B | $1.31B | $831.9M | $1.30B | $1.09B | $1.30B |
| Interest Expense | $27.7M | $52.6M | $79.4M | $73.6M | $61.0M | $54.5M | $89.6M | $110.9M | $95.0M | $95.2M |
| Pre-tax Income | $705.9M | $692.7M | $719.5M | $773.7M | $973.8M | $1.03B | $523.3M | $967.4M | $756.3M | $956.9M |
| Income Tax | $246.9M | -$50.7M | $150.9M | $157.8M | $187.9M | $204.2M | $109.4M | $211.8M | $171.0M | $220.1M |
| Net Income | $459.0M | $743.4M | $568.6M | $615.9M | $785.9M | $827.5M | $413.9M | $755.6M | $585.3M | $736.8M |
| EPS | $1.78 | $2.97 | $2.32 | $2.50 | $3.18 | $3.38 | $1.70 | $3.09 | $2.39 | $3.04 |
| EPS (Diluted) | $1.75 | $2.90 | $2.27 | $2.44 | $3.12 | $3.32 | $1.68 | $3.05 | $2.37 | $3.02 |
| Shares Outstanding (Diluted) | 262.1 M | 256.1 M | 250.7 M | 252.1 M | 252.2 M | 249.6 M | 246.3 M | 247.6 M | 246.9 M | 244.3 M |
Price
| Price | $110.45 (closing price, November 2, 2026) |
| Market Cap | $26.2B |
| Exchange | NYSE |
| Country | US |
Related companies: KMB · PG · UL · CL · CLX
Explore sector: Consumer Defensive · Household & Personal Products
More sections of CHD: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks